Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø(2024) Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study Acta Oncol, 63, 288-293 DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
Larsen SG, Graf W, Larsen RH, Revheim ME, Mariathasan AM, Sørensen O, Spasojevic M, Rashid G, Lundstrøm N, Gjertsen TJ, Aksnes AK, Bruland ØS(2024) Eighteen-Months Safety and Efficacy Following Intraperitoneal Treatment With 224Radium-Labeled Microparticles After CRS-HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer J Surg Oncol, 130(6), 1395-1402 DOI 10.1002/jso.27897, PubMed 39428687
Machak GN, Bruland ØS, Romanova TN, Kovalev AV(2024) Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal J Bone Oncol, 45, 100596 DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
